Author: Perrine

Most innovative Swiss Start-up Award – November 2019

Autumn 2019 News

New Board Members named

9th International Conference – NOTCH Targeting in Cancer

IND accepted by the FDA

Cellestia Biotech AG secures CHF 20M in Series A funding

Cellestia Winner of Venture Leaders China 2018

American Society of Clinical Oncology

New Member to the Clinical Advisory Board

New Appointment to the Clinical Advisory Board

Chairman of the Strategic Advisory Board appointed

First patient dosed in first-in-human Phase l – lla clinical study with CB-103

Regulatory approval of the Phase I-IIA study for CB-103 by Swissmedic

European Society for Medical Oncology

Oncotarget, Advance Publications 2017

Cellestia Enters Clinical Development for its Lead Compound CB-103

First Investigator Meeting for CB-103-C-101

Management Team and Scientific Advisory Board extension

American Association of Cancer Research

Cellestia in the News

New COO appointed

Cellestia Biotech raised CHF 8M

Basel Breast Consortium

European Hematology Association

American Association of Cancer Research